Original article
Xanthine oxidoreductase inhibitor topiroxostat ameliorates podocyte injury by inhibiting the reduction of nephrin and podoplanin
El inhibidor de la xantina oxidorreductasa, topiroxostat, mejora la lesión de los podocitos al inhibir la reducción de nefrina y podoplanina
Ying Zhanga, Yoshiyasu Fukusumia, Mutsumi Kayabaa, Takashi Nakamurab, Ryusuke Sakamotob, Naoki Ashizawac, Hiroshi Kawachia,
Corresponding author
a Department of Cell Biology, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan
b Pharmacological Study Group, Pharmaceutical Research Laboratories, Sanwa Kagaku Kenkyusho, Mie, Japan
c Biological Research Group, Research Department, Medical R&D Division, Fuji Yakuhin, Saitama, Japan
Read
4807
Timeswas read the article
2135
Total PDF
2672
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 138 | 121 | 259 |
| 2025 5 | 102 | 34 | 136 |
| 2025 4 | 71 | 24 | 95 |
| 2025 3 | 72 | 57 | 129 |
| 2025 2 | 69 | 56 | 125 |
| 2025 1 | 57 | 34 | 91 |
| 2024 12 | 46 | 36 | 82 |
| 2024 11 | 57 | 53 | 110 |
| 2024 10 | 68 | 53 | 121 |
| 2024 9 | 79 | 50 | 129 |
| 2024 8 | 75 | 79 | 154 |
| 2024 7 | 62 | 39 | 101 |
| 2024 6 | 54 | 58 | 112 |
| 2024 5 | 69 | 53 | 122 |
| 2024 4 | 52 | 55 | 107 |
| 2024 3 | 68 | 47 | 115 |
| 2024 2 | 48 | 85 | 133 |
| 2024 1 | 33 | 36 | 69 |
| 2023 12 | 30 | 43 | 73 |
| 2023 11 | 61 | 45 | 106 |
| 2023 10 | 120 | 64 | 184 |
| 2023 9 | 79 | 40 | 119 |
| 2023 8 | 52 | 37 | 89 |
| 2023 7 | 49 | 51 | 100 |
| 2023 6 | 40 | 31 | 71 |
| 2023 5 | 49 | 40 | 89 |
| 2023 4 | 37 | 41 | 78 |
| 2023 3 | 75 | 55 | 130 |
| 2023 2 | 63 | 28 | 91 |
| 2023 1 | 49 | 38 | 87 |
| 2022 12 | 68 | 39 | 107 |
| 2022 11 | 61 | 56 | 117 |
| 2022 10 | 73 | 88 | 161 |
| 2022 9 | 50 | 33 | 83 |
| 2022 8 | 45 | 43 | 88 |
| 2022 7 | 58 | 53 | 111 |
| 2022 6 | 52 | 49 | 101 |
| 2022 5 | 67 | 31 | 98 |
| 2022 4 | 87 | 59 | 146 |
| 2022 3 | 44 | 56 | 100 |
| 2022 2 | 52 | 52 | 104 |
| 2022 1 | 67 | 67 | 134 |
| 2021 12 | 24 | 26 | 50 |
Show all
